 Analysts expect Coherus Biosciences Inc NASDAQ:CHRS to announce sales of 100.33 million for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Coherus Biosciences earnings. The highest sales estimate is 103.73 million and the lowest is 98.30 million. Coherus Biosciences reported sales of 83.43 million during the same quarter last ... 